ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Calquence 100 mg, Filmtabletten - 60
68817001 AstraZeneca AG
Calquence 100 mg, Filmtabletten04.05.2023
  04.05.2023
Acalabrutinib (L01EL02) 
WHO-DDD03.05.2028
07.16.10.60
07.16.10. 
A  
Yes 
IPCI
4526.77Yes
    
10 %4890.70
7680688170016Synthetika
  
Composition
acalabrutinibum 100 mg ut acalabrutinibi maleas monohydricum, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, natrii stearylis fumaras, Überzug: hypromellosum, copovidonum, E 171, macrogolum 3350, triglycerida media, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium 0.59 mg.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Acalabrutinibum100 mg
BAG: Active AgentDose
Acalabrutinibum100 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Rubrum)  
Cellulosum Microcristallinum  
Copovidonum  
E 171 color.
E 172 color.
Hydroxypropylcellulosum Substitutum Humile  
Hypromellosum Überzug
Macrogol3350  
Mannitol  
Natrii Stearylis Fumaras  
Pro Compresso Obducto  
Triglycerida Media  
 
Source
Data was imported : 08.06.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home